구독하기
연구 모델
서비스
전임상 효능 평가
Resource
Lyz2-IRES-CreERT2 Mouse
제품 견적 요청
카탈로그에서 제품을 선택하여 요청을 제출해 주세요. Cyagen 팀이 상세 정보를 제공해 드립니다.
Lyz2-IRES-CreERT2 Mouse
제품명
Lyz2-IRES-CreERT2 Mouse
제품 ID
C001499
품종 계통
C57BL/6JCya-Lyz2em3(IRES-CreERT2)/Cya
Backgroud
C57BL/6JCya
Examples of Expressing Tissues/Cells
Bone marrow cell lineages (monocytes, mature macrophages, and granulocytes)
상태
이 마우스 계통을 논문에서 사용할 경우, “Lyz2-IRES-CreERT2 Mouse (카탈로그 번호 C001499)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
Inducible Cre Mouse Models
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
가격 문의
Inducible Cre Mouse Models
기본 정보
검증 데이터
관련 자료
기본 정보
유전자명
유전자 별칭
Lys, Lzm, Lzp, Lysm, Lyzs, Lyzf2, Lzm-s1
NCBI ID
염색체
Chr 10
MGI ID
Datasheet
품종 계통 설명
Lysozyme, encoded by the LYZ gene, is an integral component of the innate immune system. Its primary function is to disrupt bacterial cell walls by cleaving the β-1,4-glycosidic bond between N-acetylmuramic acid and N-acetylglucosamine in bacterial peptidoglycan, leading to bacterial lysis. Lysozyme is abundant in various secretions, including tears, saliva, human milk, and mucus, as well as in the cytoplasmic granules of macrophages and polymorphonuclear neutrophils. Cytoplasmic lysozyme expression is high in bone marrow cells, Paneth cells, and a subset of salivary gland cells [1-2].
Mice have two lysozyme-encoding genes, Lyz1 and Lyz2, which are highly homologous to the human LYZ gene. Lyz1 is primarily expressed in Paneth cells, while Lyz2 is mainly expressed in myeloid cells. Myeloid-specific expression of Lyz2 is associated with cell-type-specific demethylation of its downstream enhancer. The Lyz2 protein also has lysozyme activity and participates in defense responses against both Gram-negative and Gram-positive bacteria. Lyz2 is expressed in the hematopoietic system, liver, mesothelium, small intestine, and yolk sac of mice [3-4].
Lyz2-IRES-CreERT2 mice were generated using gene editing technology to integrate the tamoxifen-inducible CreERT2 recombinase expression element into the 3’UTR of the mouse Lyz2 gene. This mimics the expression pattern of the endogenous gene while maintaining Lyz2 expression. When bred with mice carrying a loxP site-flanked sequence, Cre recombinase-mediated recombination of the flanked sequence occurs in myeloid cells, including monocytes, mature macrophages, and granulocytes, following tamoxifen induction.
Reference
Yoshimura K, Toibana A, Nakahama K. Human lysozyme: sequencing of a cDNA, and expression and secretion by Saccharomyces cerevisiae. Biochem Biophys Res Commun. 1988 Jan 29;150(2):794-801.
Sharon N. The chemical structure of lysozyme substrates and their cleavage by the enzyme. Proc R Soc Lond B Biol Sci. 1967 Apr 18;167(1009):402-15.
Peters CW, Kruse U, Pollwein R, Grzeschik KH, Sippel AE. The human lysozyme gene. Sequence organization and chromosomal localization. Eur J Biochem. 1989 Jul 1;182(3):507-16.
Clausen BE, Burkhardt C, Reith W, Renkawitz R, Förster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999 Aug;8(4):265-77.
변형 전략
The IRES-CreERT2 gene expression element was integrated into the 3'UTR region of the mouse Lyz2 gene using gene editing technology.

Figure 1. Diagram of the gene editing strategy for the generation of Lyz2-IRES-CreERT2 mice.
검증 데이터
1. Method
Lyz2-IRES-CreERT2 mice were mated with Rosa26-LSL-tdTomato mice to generate double heterozygous zygote mice. Tamoxifen induction (3 mg/mouse for 3 days, i.p.) was performed at 8 weeks of age, resulting in Cre recombinase-mediated deletion of the LSL elements and subsequent expression of tdTomato in Cre-positive cells. One week after induction, peripheral blood was collected from the offspring, and the distribution of tdTomato was determined by flow cytometry to assess Cre recombinase expression. The control group received the same dose of corn oil.
2. Groups
Cre+Tam+: Lyz2-IRES-CreERT2[KI/+];Rosa26-LSL-tdTomato[CKI/+],Tamoxifen;
Cre+Tam-: Lyz2-IRES-CreERT2[KI/+];Rosa26-LSL-tdTomato[CKI/+], Corn oil;
Cre-Tam+: Rosa26-LSL-tdTomato[CKI/CKI], Tamoxifen.
3. Result
(1)Cre recombinase expression in peripheral blood
Cre recombinase activity and specificity were assessed in mouse peripheral blood macrophages (CD45+Cd11b+) by FACS analysis of tdTomato protein expression. Strong Cre recombinase activity was detected in macrophages from tamoxifen-induced double heterozygous mice (Cre+Tam+), with more than 90% of macrophages tdTomato-positive. However, Cre recombinase activity was undetectable in both tamoxifen-untreated double heterozygous mice (Cre+Tam-) and tamoxifen-treated Rosa26-LSL-tdTomato mice (Cre-Tam+). These results demonstrate high Cre recombinase activity and specificity under this induction regimen, with no evidence of expression leakage.

Figure 2. FACS analysis of peripheral blood macrophages.
4. Summary
In Lyz2-IRES-CreERT2 mice, Cre recombinase activity is extremely high in peripheral blood macrophages, with no evidence of pre-induction leaky expression. Our internal data show that Cre recombinase recombination efficiency in macrophages can exceed 90% following the experimental induction protocol. However, recombination efficiency drops to approximately 13% 14 days after induction is complete. Additionally, when the induction protocol is adjusted to 2 mg tamoxifen per mouse per day for 3 or 5 days, or 4 mg tamoxifen per mouse per day for 3 days, recombination efficiency in peripheral blood CD45+Cd11b+ cells is approximately 40% one week after induction is complete (data not shown).
문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
